FIELD: medicine, pharmacy.
SUBSTANCE: invention refers to the field of biochemistry, namely to an immunogenic composition comprising an antigen and a immunostimulatory oligonucleotide consisting of the nucleotide sequence' 5TCGTCGTTTTTCGGTGCTTTT3' and containing an additional pharmaceutically acceptable carrier.
EFFECT: invention allows improvement of local immune response to an antigen.
23 cl, 21 dwg, 3 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOSTIMULATING OLIGONUCLEOTIDES | 2009 |
|
RU2477753C2 |
| COMPLEX CONTAINING AN OLIGONUCLEOTIDE, HAVING IMMUNOSTIMULATING ACTIVITY, AND ITS APPLICATION | 2014 |
|
RU2723943C2 |
| IMMUNOSTIMULATING PHOSPHOROTHIOATE CpG-OLIGONUCLEOTIDES, CONTAINING PHOSPHODIESTER LINKS, METHOD OF IMMUNOMODULATION, METHOD OF IMMUNE RESPONSE STIMULATION | 2003 |
|
RU2338750C2 |
| CPG-OLIGONUCLEOTIDE ANALOGUES, CONTAINING HYDROPHOBIC T-ANALOGUES WITH AMPLIFIED IMMUNOSTIMULATORY ACTIVITY | 2007 |
|
RU2477315C2 |
| IMMUNOSTIMULATING OLIGODEOXYNUCLEOTIDES | 2001 |
|
RU2293573C2 |
| VACCINE COMPOSITION CONTAINING IMMUNE-STIMULATING OLIGODEOXYNYCLEOTIDES | 2001 |
|
RU2413520C2 |
| ANTIGEN TAU-PEPTIDES AND THEIR APPLICATION | 2010 |
|
RU2518291C2 |
| PNEUMOCOCCAL VACCINE AND USING IT | 2010 |
|
RU2536248C2 |
| SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2005 |
|
RU2393223C2 |
| INTRACELLULAR DELIVERY OF BIOMOLECULES FOR IMMUNE RESPONSE MODULATION | 2019 |
|
RU2819143C2 |
